This is a limited company view. Sign up for a Free Trial to see everything.

KalVista Pharmaceuticals - developing novel therapies for hereditary angioedema and diabetic macular edema based on small molecule plasma kallikrein inhibitors

B2B
Biotechnology
Healthcare
Medical Devices
Pharmaceuticals

Overview

Location

Bay Area

Founded

Employees

14

Stage

Public

Total funding

$30M

Last funding

3 years ago

Acquisitions

0

Growth score

17

Mindshare score

-1

Scoring

Deals

$4.0M Debt

Mar 5, 2015

$20.0M Series B

InterWest Partners, Alta Partners, Vivo Ventures

Nov 26, 2007

Other Investors

Vivo Capital

Employee Growth

Use Carbylan Therapeutics's historical employee count to better understand their growth and spending over time.

Unlock with a Free Trial

Mobile

Use Carbylan Therapeutics's mobile downloads and app ranks to evaluate the performance of their mobile apps.

Unlock with a Free Trial

Key People

VP Finance & Principal Accounting Officer
Director, Clinical Operations
Sr. Document Control Specialist II

Similar Companies

Tekmira Pharmaceuticals

Public|121 employees

Gain context with Mattermark Salesforce Enrichment

Find out how

Notes